Human medicines European public assessment report (EPAR): Herwenda, trastuzumab, Date of authorisation: 15/11/2023, Revision: 3, Status: Authorised
الصحة واللياقة البدنية
Human medicines European public assessment report (EPAR): Herwenda, trastuzumab, Date of authorisation: 15/11/2023, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Herwenda, trastuzumab, Date of authorisation: 15/11/2023, Revision: 3, Status: Authorised
AAdmin
١٨ أغسطس ٢٠٢٦
1 دقيقة قراءة
